About OralDNA
OralDNA is a company based in Eden Prairie (United States) founded in 2009 by Ken Clarke, Brian Carr, Russell Nabors, and Tom Nabors was acquired by Access Genetics in November 2012. OralDNA offers products and services including MyPerioPath, MyPerioID, and OraRisk HPV. OralDNA operates in a competitive market with competitors including Prenetics, Inflammatix, Karius, Day Zero Diagnostics and MeMed, among others.
- Headquarter Eden Prairie, United States
- Founders Ken Clarke, Brian Carr, Russell Nabors, Tom Nabors
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Access Genetics Llc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Access Genetics
(Nov 01, 2012)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of OralDNA
OralDNA offers a comprehensive portfolio of products and services, including MyPerioPath, MyPerioID, and OraRisk HPV.
Early detection tool for periodontal disease using saliva.
Targeted treatment aid for personalized oral care.
Assesses risk for HPV-related oral cancers.
Funding Insights of OralDNA
Detailed funding history for OralDNA
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in OralDNA
OralDNA has secured backing from 1 investor. Prominent investors backing the company include Access Genetics & OralDNA Labs.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Personalized diagnostics are provided through advanced DNA testing.
|
Locked | Locked | Locked |
Investor details for OralDNA
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by OralDNA
Investment portfolio details for OralDNA
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - OralDNA
Detailed financials for OralDNA
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Oraldna Comparisons
Peer comparison for OralDNA
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of OralDNA
OralDNA operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Prenetics, Inflammatix, Karius, Day Zero Diagnostics and MeMed, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Health risks are identified through online genetic and diagnostic testing.
|
|
| Locked | Locked | Locked |
Provider of diagnostic solutions for systemic infections
|
|
| Locked | Locked | Locked |
Developer of a non-invasive pathogen blood test for the detection of infectious diseases
|
|
| Locked | Locked | Locked |
Genome sequencing diagnostics for infectious diseases are developed.
|
|
| Locked | Locked | Locked |
Provider of machine learning based diagnostic solutions for infectious diseases
|
|
| Locked | Locked | Locked |
Portable PCR diagnostics for infectious diseases are developed.
|
Detailed competitors of OralDNA
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Oraldna
Complete news archive for OralDNA
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about OralDNA
OralDNA was founded in 2009.
OralDNA is headquartered in Eden Prairie, United States. It is registered at Eden Prairie, Minnesota, United States.
Brian Carr is the current CEO of OralDNA. They have also founded this company.
The company was founded in 2009 in Eden Prairie, United States, and operates in the healthcare diagnostics sector. Saliva-based molecular tests are provided for early detection of periodontal disease, HPV strains linked to oral cancers, and other infections including HSV, Candida, Chlamydia, and Neisseria gonorrhea. Genetic markers for inflammatory responses are also assessed, along with pharmacogenetic tests to predict drug responses.
OralDNA's top competitors include Visby Medical, Inflammatix and Prenetics.
OralDNA offers MyPerioPath, MyPerioID, and OraRisk HPV.
OralDNA has 1 investor. Key investors include Access Genetics & OralDNA Labs.